Wockhardt Ltd.

WOCKPHARMA

₹853.35

-0.85% (-7.3)

Market Cap

₹13,061 Cr.

P/E

0.00

About

Wockhardt Limited is a global pharmaceutical and biotechnology organisation, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare … Read more

Wockhardt Limited is a global pharmaceutical and biotechnology organisation, providing afforda… Read more

Low

213

52W Range

High

995

Quick View

CHART MODE

Price

CHART MODE

EV/EBITDA

Price to Sales

Price to Book

CHART MODE

Capex

CHART MODE

Debt

Company Timeline

Subscribe now for more updates

Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE

Latest

-13.78%

3yr Average

-12.26%

5yr Average

-3.81%

Net Profit Margin

Latest

-16.55%

3yr Average

-15.06%

5yr Average

-4.46%

ROCE

Latest

-2.36%

3yr Average

-0.51%

5yr Average

-1.45%

Debt to Equity

Latest

0.63

3yr Average

0.56

5yr Average

0.71

Market Share

0.69 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

0.05 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

0.01 %

(as of Aug 20)

Historic

Anti-Malarial - Market Share

0.05 %

(as of Nov 21)

Historic

Antineo Plastic - Market Share

4.31 %

(as of Nov 21)

Historic

Blood Related - Market Share

0 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

0.03 %

(as of Nov 21)

Historic

Dermatology - Market Share

0.62 %

(as of Nov 21)

Historic

Endocrinology - Market Share

0.45 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

0.01 %

(as of Aug 20)

Historic

Gynecology - Market Share

11 %

(as of Mar 18)

Historic

Hospitals Market Share in Ireland

0.15 %

(as of Nov 21)

Historic

Neurological - Market Share

0.01 %

(as of Feb 18)

Historic

Ophthalmology - Market Share

0.11 %

(as of Nov 21)

Historic

Pain - Market Share

0.25 %

(as of Jul 22)

Historic

Pharmaceutical Sector - Market Share

0.01 %

(as of Jul 21)

Historic

Respiratory - Market Share

0 %

(as of Jul 22)

Historic

Sex Stimulants - Market Share

0.33 %

(as of Aug 20)

Historic

Stomatological - Market Share

0.14 %

(as of May 19)

Historic

Urology - Market Share

0 %

(as of Jul 22)

Historic

Vaccines - Market Share

0.73 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Asset Break-Up

Operational Metrics

Domestic Sales Growth - YoY (%)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Brands

Spasmo Proxyvon

Suppliers

Responsive Industries Ltd.
Borosil Renewables Ltd.
Shaily Engineering Plastics Ltd.
Hindusthan National Glass & Industries Ltd.
Vivimed Labs Ltd.

FAQs on Wockhardt Ltd. Business

What does Wockhardt do?

Wockhardt Limited is a prominent Indian pharmaceutical and biotechnology company that prioritizes accessibility to high-quality medicines. They are active in Pharmaceuticals, Biotechnology, and Super Speciality Hospitals.

Who are the competitors of Wockhardt?

Wockhardt major competitors are Eris Lifesciences, Jubilant Pharmova, Caplin Point Lab, Sanofi India, Marksans Pharma, Strides Pharma Scien, Astrazeneca Pharma I.
Market Cap of Wockhardt is ₹13,061 Crs.
While the median market cap of its peers are ₹11,605 Crs.

Is Wockhardt financially stable compared to its peers?

Wockhardt seems to be less financially stable compared to its peers.
Altman Z score of Wockhardt is 2.91 and is ranked 6 out of its 8 competitors.

Company Filing

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by OpenAI	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec